Xigduo 5 mg / 850 mg – DIN 02449935
Xigduo is Dapagliflozin Propanediol Monohydrate and Metformin Hydrochloride 5 mg / 850 mg (tablet), sold in Canada. It is supplied by Astrazeneca Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Dapagliflozin Propanediol Monohydrate and Metformin Hydrochloride 5 mg / 850 mg
- Brand
- Xigduo
- Strength
- Dapagliflozin Propanediol Monohydrate 5 mg / Metformin Hydrochloride 850 mg
- Form
- Tablet
- Manufacturer
- Astrazeneca Canada Inc
- Sold in
- Canada
- DIN
- 02449935
All Dapagliflozin Propanediol Monohydrate and Metformin Hydrochloride pills and guides
Is this your medicine? Check the box
- The box or bottle shows DIN 02449935.
- It names Xigduo, Dapagliflozin Propanediol Monohydrate and Metformin Hydrochloride 5 mg / 850 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Xigduo by Astrazeneca Canada Inc.
In Canada: prescription only.
Ingredients
Active: Dapagliflozin (Dapagliflozin Propanediol Monohydrate), Metformin Hydrochloride